Posted April 6, 2020 by jennysmith
Cutaneous Leishmaniasis Drugs market was valued at USD 40.5 Million in 2018 and is projected to reach USD 56.1 Million by 2026, growing at a CAGR of 4.23% from 2019 to 2026.
Contact Email | [email protected] |
Issued By | vmr |
Country | United States |
Categories | Business |
Tags | cutaneous leishmaniasis drugs market |
Last Updated | April 6, 2020 |